An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen Health

Medical weight loss in Minneapolis

Minneapolis residents on Medical Assistance, Minnesota's Medicaid program, may have weight-loss GLP-1s covered, because the state was still listed as covering them in 2026 [1]. Paying cash instead, Zepbound (tirzepatide) costs $299 to $449 a month through LillyDirect [2], and the GLP-1 tablets start at $149 [3].

Updated Oct 17, 2026By the Wellchosen Health editorial team

Medical review: pending. A licensed clinician has not yet reviewed this page.

Medical weight loss is obesity treatment overseen by a licensed clinician, typically a prescription drug plus eating and activity support and regular check-ins.

Hennepin County adults with obesity
27.1% [4]
Minnesota Medical Assistance
Listed as covering obesity GLP-1s in 2026 [1]
Zepbound cash price
$299 to $449 a month [2]
Minneapolis median household income
$80,846 [5]
Share of residents 65+
11.4% [5]

Compare tirzepatide costs

Tirzepatide for Minneapolis patients

Zepbound, Lilly's tirzepatide brand, carries two labeled uses: long-term weight management, and obstructive sleep apnea in adults who have obesity [6]. A Minneapolis buyer paying LillyDirect directly spends $299 on 2.5 mg, $399 on 5 mg and $449 on any strength from 7.5 to 15 mg, as long as refills land within 45 days [2]. Kept up for twelve months at the top tier, that is $5,388, or roughly 6.7% of the city's $80,846 median household income [5]. SURMOUNT-1 participants on 15 mg averaged a 20.9% loss of body weight by week 72 [7]; our Zepbound results page explains what that average hides.

Sponsored listing, labeled. It is not a ranking or an endorsement. Practices can visit sponsor a city.

A state that still pays through Medicaid

Stateline's April 2026 report, drawing on KFF, put Minnesota on the short list of states whose Medicaid programs pay for obesity GLP-1s [1]; KFF's January count of such states was 13 [8]. Ask your Medical Assistance plan which brand it prefers and what paperwork it wants. Only 11.4% of Minneapolis residents are 65 or older [5], but those on Part D can look at the Medicare GLP-1 Bridge: $50 a month for Wegovy, Foundayo or a Zepbound KwikPen if they meet its rules [9] [10]. More on GLP-1 coverage and Medicare.

Lilly and Novo cash prices

What Minneapolis buyers pay the makers each month (Oct 17, 2026)
MedicineHow takenMonthlyRef
FoundayoTablet, once a day$149 to $299[3]
WegovyTablet, once a day$149 to $299[11]
WegovyPen, once a week$349[11]
ZepboundVial or KwikPen, once a week$299 to $449[2]
Drug only. Every dose and channel: GLP-1 cost comparison.

Hennepin County data and local checks

CDC PLACES places Hennepin County's adult obesity rate at 27.1% and its diabetes rate at 8.1%; inside Minneapolis the model reads 28.6% and 7.4% [4] [12]. We were unable to confirm a local hospital weight program and its price this month, so none is named. Your primary care clinic is the first call. The Minnesota Board of Medical Practice is where a prescriber's license can be confirmed [13].

Minnesota law adds a referral rule: Minn. Stat. 147.091 lets the board discipline a physician who takes a commission or rebate mainly for referring patients or for prescribing a drug [17]. A clinic paying influencers per signup deserves a second look. Then compare tirzepatide online and the clinic checklist.

Other Midwest guides: Kansas City, Chicago, Detroit. Also semaglutide in Minneapolis and the weight loss hub.

About compounded tirzepatide

No compounded tirzepatide has FDA approval, and FDA does not check these products for safety, effectiveness or quality. By May 31, 2026, FDA had logged more than 730 adverse event reports tied to compounded tirzepatide [14]. The period when pharmacies could routinely compound tirzepatide copies ended March 5, 2025 [15].

Zepbound label points

In rats, tirzepatide caused thyroid C-cell tumors, so Zepbound has a boxed warning and must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 [16]. Seek care for stomach pain that is severe and persistent, for signs of an allergic reaction, or for lows if insulin or a sulfonylurea is also in the mix. Stop when pregnancy is recognized. Emergencies: 911.

Questions people ask

What does tirzepatide cost in Minneapolis without insurance?

On Oct 17, 2026, LillyDirect sold Zepbound for $299 to $449 a month, the price rising with the dose [2].

Does Minnesota Medical Assistance pay for weight-loss GLP-1s?

Stateline, citing KFF, listed Minnesota's Medicaid program among those covering GLP-1s for obesity in 2026 [1]. Your plan decides which brand and what proof of need.

How common is obesity in Hennepin County and Minneapolis?

CDC PLACES estimates 27.1% of Hennepin County adults and 28.6% of Minneapolis adults have obesity [4] [12].

Which GLP-1 has the lowest cash price for a Minneapolis buyer?

The Foundayo tablet and the Wegovy tablet both cost $149 a month at their starting strength, checked Oct 17, 2026 [3] [11].

Can a Minnesota doctor take payments for referring weight loss patients?

Minn. Stat. 147.091 makes taking a commission or rebate primarily for patient referrals, or for prescribing drugs, grounds for board discipline [17].

Will the Medicare Bridge cover a Zepbound vial?

No. The Bridge pays only for the Zepbound KwikPen, not the single-dose vial [10].

Sources

17 cited
  1. More states consider dropping GLP-1 weight loss drugs from Medicaid. Stateline (States Newsroom), Apr 30, 2026.
  2. Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  3. Foundayo self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  4. PLACES county data, 2025 release: Hennepin County, MN. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
  5. QuickFacts: Minneapolis city, Minnesota. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
  6. Zepbound label. DailyMed, National Library of Medicine, Aug 2026.
  7. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), 2022.
  8. Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
  9. Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), Oct 17, 2026.
  10. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, Oct 17, 2026.
  11. Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
  12. PLACES place data, 2025 release: Minneapolis, MN. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
  13. Contact a state medical board. Federation of State Medical Boards, Oct 17, 2026.
  14. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
  15. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. U.S. Food and Drug Administration, Apr 1, 2026.
  16. Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
  17. Minnesota Statutes 147.091. Minnesota Office of the Revisor of Statutes, accessed 2026-10-17.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Compare tirzepatide costs